Treatment of gum disease and bone loss with the medicine made from patient blood and artificial bone
Phase 4
- Registration Number
- CTRI/2019/01/017225
- Lead Sponsor
- ESHA THAKOR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having moderate to severe periodontitis, patients who are systemically healthy and having more than 6 mm vertical probing depth, having interproximal intrabony defects of more than or equal to 4 mm one on either side of the arch which is radiographically detectable will be included.
Exclusion Criteria
Patients who are known case of systemic disease, having abusive habits such as smoking, women who are pregnant or lactating, who are taking anti-inflammatory or antibiotic drugs or has taken within previous 3 months and patients who have done blood transfusion or blood donation in last 6 months will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Radiographic measurements using CBCTTimepoint: BASELINE AND 6 MONTHS
- Secondary Outcome Measures
Name Time Method Site specific plaque index (PI) <br/ ><br>modified Sulcus bleeding index (mSBI) <br/ ><br>Probing depth (PD) from the gingival margin <br/ ><br>Clinical attachment level (CAL) along with gingival marginal level (GML)Timepoint: BASELINE AND 6 MONTHS